Azithromycin through the Lens of the COVID-19 Treatment
Azithromycin has become famous in the last two years, not for its main antimicrobial effect, but for its potential use as a therapeutic agent for COVID-19 infection. Initially, there were some promising results that supported its use, but it has become clear that scientific results are insufficient...
Main Authors: | Georgia G. Kournoutou, George Dinos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/8/1063 |
Similar Items
-
The Immunomodulatory Effects of Macrolides—A Systematic Review of the Underlying Mechanisms
by: Petra Zimmermann, et al.
Published: (2018-03-01) -
AZITHROMYCIN IN THERAPY OF BACTERIAL RHINOSINUSITES
by: A. A. Krivopalov, et al.
Published: (2017-07-01) -
The effect of erythromycin and clarithromycin versus azithromycin on serum valproate concentration
by: Muradi Albanji, et al.
Published: (2022-04-01) -
Update on azithromycin and cardiac side effects
by: Minji Kim, et al.
Published: (2013-12-01) -
Novel Knowledge of Macrolide Resistance in <i>Mycoplasma pneumoniae</i> by Azithromycin Exposure
by: Tomohiro Oishi, et al.
Published: (2024-01-01)